Mature myeloid dendritic cells for clinical use prepared from CD14+ cells isolated by immunomagnetic adsorption

Journal of Hematotherapy and Stem Cell Research

Volumn 10, Issue 3, 2001, Pages 427-429

  Padley, D J ^a   Dietz, A B ^b   Gastineau, D A ^a,c   Vuk Pavlovic S ^b,c  

^a Division of Laboratory Medicine   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ADSORPTION; APHERESIS; ARTICLE; CELL SEPARATION; CHRONIC MYELOID LEUKEMIA; DENDRITIC CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL;

ANTIGENS, CD; ANTIGENS, CD14; BLOOD CELLS; CELLS, CULTURED; CULTURE MEDIA; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULINS; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; LEUKEMIA, MYELOID, CHRONIC; MEMBRANE GLYCOPROTEINS;

EID: 0034924155     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581601750289037     Document Type: Article

References (4)

1. Optimizing preparation of normal dendritic cells and bcr-abl positive mature dendritic cells derived from immunomagnetically purified CD14 positive cells
2. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
3. + T cells
4. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions